2m 2m 2m 2m 2m 2m 2m
ORTHOPEDIATRICS (KIDS)
NASDAQ
$18.38+$0.005 (+0.03%)
Price as of Jun 23, 2026 4:10 PM EDT- $466.4MMarket Cap
- -14.26%1-Year Change
- Medical DevicesIndustry
ORTHOPEDIATRICS (KIDS)
$18.38+$0.005 (+0.03%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 236.3M +15.45% | 204.7M +37.65% | 148.7M +21.62% | 122.3M +24.72% | |
Cost of Revenue | 63.7M +13.47% | 56.1M +49.76% | 37.5M +18.50% | 31.6M +28.33% | |
Gross Profit | 172.7M +16.19% | 148.6M +33.57% | 111.3M +22.71% | 90.7M +23.51% | |
Sales and Marketing Expense | 72.7M +13.11% | 64.3M +25.08% | 51.4M +14.09% | 45.1M +13.56% | |
Research and Development Expense | -9.1M -17.51% | -11.0M +8.22% | -10.2M +27.23% | -8.0M +44.58% | |
Depreciation and Amortization Expense | 21.1M +10.69% | 19.1M +9.75% | 17.4M +32.72% | 13.1M +22.65% | |
Total Operating Expenses | 211.9M +15.41% | 183.6M +33.05% | 138.0M +18.91% | 116.1M +26.94% | |
Operating Profit | -39.2M +12.08% | -35.0M +30.87% | -26.8M +5.32% | -25.4M +40.92% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -27,000 -22.86% | -35,000 -16.67% | -42,000 -98.27% | -2.4M +7.88% | |
Interest Income and Expense and Net | -27,000 -22.86% | -35,000 -16.67% | -42,000 -98.27% | -2.4M +7.88% | |
Total Nonoperating Income and Expense | 50,000 +100.72% | -6.9M -227.21% | 5.4M -74.95% | 21.7M +3,313.52% | |
Income before Taxes | -39.2M -6.54% | -41.9M +96.74% | -21.3M +477.72% | -3.7M -78.78% | |
Income Taxes | 460,000 +111.20% | -4.1M +1,115.09% | -338,000 -93.17% | -4.9M +338.56% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -39.6M +4.83% | -37.8M +80.33% | -21.0M -1,767.25% | 1.3M +107.74% | |
Net Income from Continuing Operations Applicable to Common | -39.2M -6.54% | -41.9M +96.74% | -21.3M +477.72% | -3.7M -78.78% | |
Basic EPS and Net Income | -1.69 +3.05% | -1.64 +78.26% | -0.92 -1,633.33% | 0.06 +107.14% | |
Diluted EPS and Net Income | -1.69 +3.05% | -1.64 +78.26% | -0.92 -1,633.33% | 0.06 +107.14% | |
Basic Weighted Average Shares | 23.5M +1.65% | 23.1M +1.77% | 22.7M +9.52% | 20.7M +7.45% | |
Diluted Weighted Average Shares | 23.5M +1.65% | 23.1M +1.77% | 22.7M +8.25% | 20.9M +8.72% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 19.6M -55.37% | 43.8M +41.10% | 31.1M +245.40% | 9.0M +17.67% | |
Short-Term Investments | 41.3M +65.09% | 25.0M -49.21% | 49.3M -54.94% | 109.3M +138.11% | |
Cash and Cash Equivalents and Short-Term Investments | 60.9M -11.60% | 68.8M -14.29% | 80.3M -32.11% | 118.3M +120.93% | |
Total Current Assets | 256.4M +8.11% | 237.2M +4.71% | 226.5M -0.10% | 226.7M +69.64% | |
Accumulated Depreciation | 57.9M +25.47% | 46.1M +16.49% | 39.6M +28.52% | 30.8M +33.41% | |
Property and Plant and Equipment and Net | 49.6M -2.06% | 50.6M +23.26% | 41.0M +19.72% | 34.3M +20.24% | |
Total Long-Term Assets | 15.7M +50.48% | 10.4M +254.32% | 2.9M -91.43% | 34.3M +20.24% | |
Total Assets | 508.6M +7.49% | 473.2M +7.86% | 438.7M +2.58% | 427.7M +40.57% | |
Income Taxes Payable | 3.6M +5.94% | 3.4M -38.34% | 5.5M -7.91% | 6.0M +24.80% | |
Total Short-Term Debt | 13.6M +16.57% | 11.6M +7,553.95% | 152,000 +5.56% | 144,000 +5.11% | |
Total Current Liabilities | 46.2M +36.03% | 34.0M -18.49% | 41.7M +34.97% | 30.9M +3.89% | |
Total Long-Term Debt | 99.5M +36.43% | 73.0M +636.33% | 9.9M +1,198.56% | 763,000 -15.88% | |
Total Long-Term Liabilities | 115.8M +36.79% | 84.7M +322.26% | 20.1M +10.14% | 18.2M -62.98% | |
Total Liabilities | 162.0M +36.57% | 118.6M +92.23% | 61.7M +25.76% | 49.1M -37.80% | |
Retained Earnings | -275.2M +16.83% | -235.6M +19.13% | -197.7M +11.87% | -176.8M -0.71% | |
Total Stockholders Equity | 346.6M -2.25% | 354.6M -5.96% | 377.0M -0.43% | 378.6M +68.01% | |
Total Shares Outstanding | 25.1M +3.62% | 24.2M +3.59% | 23.4M +2.19% | 22.9M +16.27% | |
Cash Flow | |||||
Cash from Operating Activities | -4.9M -82.07% | -27.0M +0.007% | -27.0M +24.26% | -21.8M +66.62% | |
Capital Expenditures | 11.1M -22.11% | 14.3M -15.49% | 16.9M +68.26% | 10.0M +23.79% | |
Cash from Investing Activities | -43.6M +231.48% | -13.2M -131.58% | 41.7M +136.76% | -113.4M +1,429.77% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 24.0M -54.88% | 53.1M +627.78% | 7.3M -94.63% | 136.0M +2,266,133.33% | |
Financials Ratio | |||||
Gross Margin | 73.05% +0.65% | 72.58% -2.96% | 74.80% +0.90% | 74.14% -0.97% | |
Operating Margin | -16.60% -2.92% | -17.10% -4.92% | -17.99% -13.40% | -20.77% +12.99% | |
Return on Assets | -8.08% -2.63% | -8.29% +71.34% | -4.84% -1,508.55% | 0.34% +106.60% | |
Return on Equity | -11.31% +9.38% | -10.34% +86.26% | -5.55% -1,432.80% | 0.42% +105.89% | |
Revenue Growth | 15.45% -58.97% | 37.65% +74.11% | 21.62% -12.53% | 24.72% -34.85% | |
Current Ratio | 5.55 -20.52% | 6.98 +28.47% | 5.44 -25.98% | 7.34 +63.29% | |
Cash Ratio | 0.42 -67.19% | 1.29 +73.12% | 0.75 +155.94% | 0.29 +13.26% | |
Debt-to-Equity Ratio | 0.33 +36.76% | 0.24 +793.63% | 0.03 +1,012.50% | 0.002 -47.83% | |
Debt-to-Assets Ratio | 0.22 +24.38% | 0.18 +680.79% | 0.02 +990.48% | 0.002 -38.24% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow